{"id":"https://openalex.org/W1547353064","doi":"https://doi.org/10.1002/pds.2348","title":"Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate","display_name":"Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-17","ids":{"openalex":"https://openalex.org/W1547353064","doi":"https://doi.org/10.1002/pds.2348","mag":"1547353064","pmid":"https://pubmed.ncbi.nlm.nih.gov/22253017"},"language":"en","primary_location":{"id":"doi:10.1002/pds.2348","doi":"https://doi.org/10.1002/pds.2348","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2348","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1547353064"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039009338","display_name":"Carlos Trece\u00f1o Lobato","orcid":"https://orcid.org/0009-0008-0581-0949","observed_orcids":["https://orcid.org/0009-0008-0581-0949"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlos Trece\u00f1o","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018339918","display_name":"Luis H. Mart\u00edn Arias","orcid":"https://orcid.org/0000-0002-3815-8781","observed_orcids":["https://orcid.org/0000-0002-3815-8781"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luis H. Mart\u00edn Arias","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102751420","display_name":"Mar\u00eda S\u00e1inz-Gil","orcid":"https://orcid.org/0000-0002-4353-055X","observed_orcids":["https://orcid.org/0000-0002-4353-055X"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria S\u00e1inz","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025465222","display_name":"In\u00e9s Salado Valdivieso","orcid":"https://orcid.org/0000-0003-4879-608X","observed_orcids":["https://orcid.org/0000-0003-4879-608X"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"In\u00e9s Salado","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103817348","display_name":"Pilar Garc\u00eda Ortega","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pilar Garc\u00eda Ortega","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101452364","display_name":"Ver\u00f3nica Velasco","orcid":"https://orcid.org/0000-0003-4739-9760","observed_orcids":["https://orcid.org/0000-0003-4739-9760"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronica Velasco","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060176256","display_name":"Natalia Jimeno Bulnes","orcid":"https://orcid.org/0000-0002-9618-3424","observed_orcids":["https://orcid.org/0000-0002-9618-3424"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Natalia Jimeno","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113542330","display_name":"Antonio Escudero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Escudero","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109456177","display_name":"Alfonso Velasco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfonso Velasco","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011209485","display_name":"Alfonso Carvajal","orcid":"https://orcid.org/0000-0001-8224-695X","observed_orcids":["https://orcid.org/0000-0001-8224-695X"]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alfonso Carvajal","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda Universidad de Valladolid  Valladolid Spain","institution_ids":["https://openalex.org/I108103353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5011209485"],"corresponding_institution_ids":["https://openalex.org/I108103353"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":3.8961,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.932683,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"21","issue":"4","first_page":"435","last_page":"441"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11953","display_name":"Neuroethics, Human Enhancement, Biomedical Innovations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/extended-release-methylphenidate","display_name":"extended-release methylphenidate","score":0.9670000076293945},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8949999809265137},{"id":"https://openalex.org/keywords/amphetamine-withdrawal","display_name":"amphetamine withdrawal","score":0.8740000128746033},{"id":"https://openalex.org/keywords/stimulant-prescribing","display_name":"stimulant prescribing","score":0.5289999842643738},{"id":"https://openalex.org/keywords/overdiagnosis","display_name":"overdiagnosis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/inappropriate-prescribing","display_name":"inappropriate prescribing","score":0.7519999742507935},{"id":"https://openalex.org/keywords/consumption-trends","display_name":"consumption trends","score":0.48500001430511475},{"id":"https://openalex.org/keywords/castile-and-leon","display_name":"Castilla y Le\u00f3n","score":0.7549999952316284},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.6980000138282776},{"id":"https://openalex.org/keywords/medication-dispensing","display_name":"medication dispensing","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.8702644109725952},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7374409437179565},{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.7129977941513062},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7054972052574158},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.6337012052536011},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.5738792419433594},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.47836774587631226},{"id":"https://openalex.org/C3017694942","wikidata":"https://www.wikidata.org/wiki/Q16254243","display_name":"Attention deficit","level":3,"score":0.4284363389015198},{"id":"https://openalex.org/C2994409691","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit disorder","level":2,"score":0.41006767749786377},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3698888421058655},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3509807884693146},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.34832167625427246},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.32537567615509033},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2904055118560791},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2583422362804413},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1011631190776825},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.2348","doi":"https://doi.org/10.1002/pds.2348","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2348","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:22253017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22253017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W132397449","https://openalex.org/W136165923","https://openalex.org/W1841183858","https://openalex.org/W1965390021","https://openalex.org/W1966200243","https://openalex.org/W1967354822","https://openalex.org/W1969668374","https://openalex.org/W1973510512","https://openalex.org/W1985488933","https://openalex.org/W2005032555","https://openalex.org/W2032285255","https://openalex.org/W2033304004","https://openalex.org/W2035761153","https://openalex.org/W2038382332","https://openalex.org/W2046837347","https://openalex.org/W2057459801","https://openalex.org/W2062005463","https://openalex.org/W2084587729","https://openalex.org/W2085046856","https://openalex.org/W2099805984","https://openalex.org/W2104212239","https://openalex.org/W2123980944","https://openalex.org/W2127278987","https://openalex.org/W2130386846","https://openalex.org/W2145163559","https://openalex.org/W2155350946","https://openalex.org/W2165705294","https://openalex.org/W2168174199","https://openalex.org/W2171074660","https://openalex.org/W2179019266","https://openalex.org/W2330451900","https://openalex.org/W4235755856","https://openalex.org/W4237494114","https://openalex.org/W4242085437","https://openalex.org/W4255542068"],"related_works":["https://openalex.org/W2765627220","https://openalex.org/W4221166312","https://openalex.org/W102816399","https://openalex.org/W1915124925","https://openalex.org/W2597662428","https://openalex.org/W2893356222","https://openalex.org/W1546510252","https://openalex.org/W2769578003","https://openalex.org/W2519289322"],"abstract_inverted_index":{"BACKGROUND:":[0],"Attention":[1,115],"deficit":[2,116],"hyperactivity":[3,117],"disorder":[4,11,118],"(ADHD)":[5],"is":[6,233],"the":[7,28,34,40,46,49,64,83,86,180,216,231],"most":[8],"diagnosed":[9],"behavioural":[10],"in":[12,27,55,95,122,130,136,163,174,198,207,211,215,230],"children":[13],"and":[14,48,75,187,239],"adolescents;":[15],"prevalence":[16],"has":[17,202],"been":[18,203],"estimated":[19],"around":[20],"5%.":[21],"Studies":[22],"have":[23],"shown":[24],"an":[25,204],"increase":[26,152,206,220,229],"use":[29],"of":[30,39,51,77,85,157,182,195],"ADHD":[31,52,208],"medications":[32,78],"during":[33],"last":[35,217],"years.":[36],"The":[37,91,147],"aim":[38],"present":[41],"study":[42],"was":[43,112,170,225],"to":[44,109,132,167,185],"learn":[45],"pattern":[47],"evolution":[50],"medication":[53,119,209],"consumption":[54,74,111,120,139,181,210,232],"Castilla":[56,123,212],"y":[57,124,213],"Le\u00f3n":[58,125,214],"(Spain).":[59],"METHOD:":[60],"Consumption":[61],"data":[62,92],"for":[63,150],"period":[65],"1992-2009":[66],"were":[67,93,153],"obtained":[68],"from":[69,126],"databases":[70],"containing":[71],"information":[72],"upon":[73],"cost":[76],"dispensed":[79],"by":[80,145],"pharmacies":[81],"at":[82],"expense":[84],"Spanish":[87],"National":[88],"Health":[89],"System.":[90],"expressed":[94],"defined":[96],"daily":[97],"doses":[98],"(DDDs)":[99],"per":[100,103],"1000":[101],"inhabitants":[102],"day":[104],"(DDD/1000":[105],"inhabitants/day).":[106],"A":[107,227],"model":[108],"forecast":[110],"built.":[113],"RESULTS:":[114],"increased":[121],"0.1":[127],"DDD/1000":[128,134,143,161],"inhabitants/day":[129,135,144,162],"1992":[131,166],"1.5":[133],"2009;":[137],"expected":[138],"will":[140],"reach":[141],"2.5":[142],"2013.":[146],"drugs":[148],"accounting":[149],"this":[151],"mainly":[154],"made":[155],"up":[156],"methylphenidate":[158,175,224],"preparations":[159],"(1.4":[160],"2009).":[164],"From":[165],"1999,":[168],"there":[169],"a":[171,190,234],"slight":[172],"reduction":[173],"use;":[176],"following":[177],"amphetamine":[178],"withdrawal,":[179],"stimulants":[183],"began":[184],"increase,":[186],"figures":[188],"showed":[189],"sharp":[191],"rise":[192],"after":[193],"marketing":[194],"extended-release":[196,223],"formulations":[197],"2003.":[199],"CONCLUSIONS:":[200],"There":[201],"enormous":[205],"few":[218],"years;":[219],"rocketed":[221],"when":[222],"marketed.":[226],"rapid":[228],"warning":[235],"on":[236],"possible":[237],"overdiagnosis":[238],"inappropriate":[240],"prescription.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1547353064","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
